Table 1.
Type of model/injury | Species | Intervention | In vivo or in vitro | Effect of intervention on liver | Reference |
---|---|---|---|---|---|
Viral hepatitis | Mouse | Platelet depletion | In vivo | Hepatoprotective | 47 |
Viral hepatitis | Mouse | Inhibition of platelet activation | In vitro and in vivo | Hepatoprotective | 12, 13, 48, 49, 50, 51 |
Viral hepatitis | Mouse | Blocking platelet binding to endothelium | In vitro and in vivo | Variable can be either hepatoprotective or hepatotoxic | 5, 12 |
Isolated HSEC coculture with platelets | Human | Blocking platelet binding to endothelium | In vitro | Hepatoprotective (reduced effector cell recruitment) | 5 |
Ischemia‐reperfusion | Mouse | Blocking platelet‐Kupffer cell interaction | In vivo | Hepatoprotective (reduction in steatosis) | 42, 45, 46 |
Thermal injury | Mouse | Blocking platelet binding | In vivo | Hepatotoxic (reduced neutrophil‐mediated repair) | 30 |
Acute cholestasis | Mouse | Inhibition of platelet activation | In vivo | Hepatoprotective | 58, 59, 60 |
Chronic cholestasis | Mouse | Platelet depletion/inhibition of platelet activation | In vivo | Hepatotoxic (worsens fibrosis) | 62, 63 |